MARCHF2 Protein
Overview
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">MARCHF2 Protein</th>
</tr>
<tr>
<td class="label">Partner Protein</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">TRAF6</td>
<td>Negative regulation</td>
</tr>
<tr>
<td class="label">EGFR</td>
<td>Substrate</td>
</tr>
<tr>
<td class="label">p62/SQSTM1</td>
<td>Autophagy receptor</td>
</tr>
<tr>
<td class="label">LC3</td>
<td>Autophagy adapter</td>
</tr>
<tr>
<td class="label">MHC class I</td>
<td>Ubiquitination</td>
</tr>
<tr>
<td class="label">Parkin</td>
<td>Functional cooperation</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
MARCHF2 (Membrane-Associated RING-CH Finger 2), also known as MARCH2, is an E3 ubiquitin ligase belonging to the MARCH family of membrane-associated RING-CH proteins. Originally discovered as immune regulatory molecules, MARCH proteins have emerged as important regulators of cellular membrane trafficking, protein quality control, and autophagy[@barcz2004]. In the nervous system, MARCHF2 plays critical roles in neuronal function and has been implicated in the pathogenesis of neurodegenerative diseases including Alzheimer's disease (AD) and Parkinson's disease (PD)[@samii2009].
...
MARCHF2 Protein
Overview
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">MARCHF2 Protein</th>
</tr>
<tr>
<td class="label">Partner Protein</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">TRAF6</td>
<td>Negative regulation</td>
</tr>
<tr>
<td class="label">EGFR</td>
<td>Substrate</td>
</tr>
<tr>
<td class="label">p62/SQSTM1</td>
<td>Autophagy receptor</td>
</tr>
<tr>
<td class="label">LC3</td>
<td>Autophagy adapter</td>
</tr>
<tr>
<td class="label">MHC class I</td>
<td>Ubiquitination</td>
</tr>
<tr>
<td class="label">Parkin</td>
<td>Functional cooperation</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
MARCHF2 (Membrane-Associated RING-CH Finger 2), also known as MARCH2, is an E3 ubiquitin ligase belonging to the MARCH family of membrane-associated RING-CH proteins. Originally discovered as immune regulatory molecules, MARCH proteins have emerged as important regulators of cellular membrane trafficking, protein quality control, and autophagy[@barcz2004]. In the nervous system, MARCHF2 plays critical roles in neuronal function and has been implicated in the pathogenesis of neurodegenerative diseases including Alzheimer's disease (AD) and Parkinson's disease (PD)[@samii2009].
The MARCH family comprises 11 members (MARCHF1-MARCHF11) in humans, characterized by a RING-CH (R-CH) domain that mediates E3 ubiquitin ligase activity. Unlike classical RING finger proteins, the CH-type RING domain confers membrane association and specific substrate recognition, enabling MARCH proteins to regulate diverse cellular processes including endosomal trafficking, receptor signaling, and autophagy[@morohashi2020].
- Protein Name: MARCHF2 (MARCH2)
- UniProt ID: Q9P2R3
- Gene: [MARCHF2](/genes/marchf2)
- Molecular Weight: ~28 kDa
- Protein Class: E3 ubiquitin ligase, membrane-associated RING-CH protein
- Tissue Expression: Ubiquitous, high in brain, heart, lung
- Subcellular Localization: Endosomes, plasma membrane, Golgi apparatus
Molecular Structure
MARCHF2 contains several distinct structural domains that mediate its cellular functions:
RING-CH Domain (RCH)
- Located at the N-terminus
- Contains the characteristic C3H2C3 RING finger motif with a CH-type zinc finger
- Mediates E3 ubiquitin ligase activity
- Catalyzes ubiquitin transfer to substrate proteins[@samii2009]
Transmembrane Regions
- Two transmembrane helices (TM1 and TM2)
- Anchor the protein to cellular membranes
- Target MARCHF2 to endosomes, plasma membrane, and Golgi apparatus[@cheng2011]
Coiled-Coil Domain
- Mediates protein-protein interactions
- Facilitates dimerization or oligomerization
- Important for substrate recognition
C-Terminal Tail
- Cytoplasmic domain facing the cytosol
- Contains additional regulatory motifs
- May participate in protein complex formation
Normal Physiological Functions
Endosomal Trafficking Regulation
MARCHF2 plays a central role in regulating endosomal trafficking pathways:
Endosome Maturation and Sorting
- Regulates early-to-late endosome transition
- Controls cargo sorting into intralumenal vesicles for exosome formation
- Modulates receptor degradation in lysosomes[@cheng2011]
Receptor Trafficking
- Regulates EGFR (Epidermal Growth Factor Receptor) trafficking and degradation
- Controls transferrin receptor recycling
- Modulates cytokine receptor surface expression[@barcz2004]
Membrane Protein Quality Control
- Targets misfolded or excess membrane proteins for degradation
- Participates in ER-associated degradation (ERAD) of membrane proteins
- Prevents accumulation of abnormal membrane proteins
Immune System Regulation
MARCHF2 was originally characterized as an immune regulatory molecule:
Immune Receptor Modulation
- Regulates MHC class I molecule trafficking and expression
- Modulates T-cell receptor (TCR) signaling
- Controls costimulatory molecule expression[@barcz2004]
NF-κB Signaling
- Negatively regulates TRAF6-mediated NF-κB activation
- Limits inflammatory signaling in immune cells
- Prevents excessive immune activation[@shin2021]
Autophagy Regulation
MARCHF2 intersects with autophagy pathways to regulate cellular homeostasis:
Autophagosome Formation
- Regulates initiation of autophagy
- Controls autophagosome-lysosome fusion
- Modulates selective autophagy pathways[@yan2020]
Selective Autophagy Substrates
- Can be ubiquitinated and targeted for autophagic degradation
- Interacts with autophagy receptor proteins
- Contributes to aggrephagy and mitophagy[@lawrence2021]
Role in Neurodegenerative Diseases
Alzheimer's Disease
MARCHF2 is implicated in AD pathogenesis through multiple mechanisms:
APP Processing and Aβ Generation
- Regulates APP (Amyloid Precursor Protein) trafficking through endosomal pathways
- Influences β- and γ-secretase processing of APP
- May affect amyloid-beta ([Aβ](/proteins/amyloid-beta)) production and secretion
- Endosomal dysfunction is an early feature of AD pathology
Protein Quality Control
- Contributes to ubiquitin-proteasome system function in neurons
- Helps clear misfolded proteins from the endoplasmic reticulum
- Participates in aggrephagy (aggregation-induced autophagy)
Neuroinflammation
- Modulates NF-κB signaling in glial cells
- Can regulate microglial activation and inflammatory responses
- Contributes to chronic neuroinflammation in AD
Tau Pathology
- May affect tau ([MAPT](/genes/mapt)) degradation pathways
- Implicated in tau propagation through exosome secretion
- Could influence tau aggregation and spread
Parkinson's Disease
MARCHF2 plays important roles in PD through regulation of protein clearance and mitochondrial quality control:
Autophagy-Lysosome Pathway
- Critical for proper autophagic flux in dopaminergic neurons
- Regulates clearance of [alpha-synuclein](/proteins/alpha-synuclein) aggregates
- Impaired MARCHF2 function may contribute to Lewy body formation
- Endosomal-lysosomal pathway dysfunction is a hallmark of PD pathology[@zhang2020]
Mitophagy and Mitochondrial Quality Control
- Promotes mitophagy in dopaminergic neurons
- Protects against mitochondrial toxins (e.g., MPTP)
- Maintains mitochondrial network integrity
- Prevents accumulation of damaged mitochondria
Protein Homeostasis
- Contributes to ubiquitin-proteasome system function
- Helps clear damaged or misfolded proteins
- Prevents toxic protein aggregate formation
- Supports neuronal survival under proteostatic stress
Amyotrophic Lateral Sclerosis (ALS)
MARCHF2 may contribute to ALS pathogenesis:
TDP-43 Proteinopathy
- Regulates trafficking of TDP-43 (TARDBP) protein
- May affect TDP-43 aggregation and cytoplasmic mislocalization
- Implicated in ubiquitin-positive inclusions in ALS
Protein Aggregate Clearance
- Contributes to autophagy-mediated clearance of protein aggregates
- May be affected by mutations in ALS-associated genes
- Helps maintain proteostasis in motor neurons
Huntington's Disease
MARCHF2 may play protective roles in HD:
Mutant Huntingtin Clearance
- May promote autophagy-dependent clearance of mutant huntingtin
- Protects against polyglutamine toxicity
- Supports neuronal survival
Transcriptional Regulation
- May affect gene expression through NF-κB modulation
- Influences inflammatory responses in HD
Protein Interactions
MARCHF2 interacts with several key cellular proteins:
Therapeutic Implications
MARCHF2 represents a potential therapeutic target for neurodegenerative diseases:
Small Molecule Modulators
- MARCHF2 activators: Enhance E3 ligase activity to boost protein clearance
- MARCHF2 inhibitors: Reduce excessive immune activation in neuroinflammation
- Modulators of MARCHF2-autophagy interaction: Enhance aggregate clearance
Gene Therapy Approaches
- AAV-mediated MARCHF2 expression: Restore function in deficient neurons
- RNAi-mediated knockdown: Reduce pathological activity if overactive
Combination Strategies
- MARCHF2 activation + autophagy enhancers: Synergistic protein clearance
- MARCHF2 + proteasome modulators: Comprehensive protein quality control
- MARCHF2 + mitochondrial protectants: Multi-target neuroprotection
Signaling Pathway Diagram
Mermaid diagram (expand to render)
Research Models
In Vitro Models
- Cell lines: HEK293, SH-SY5Y neuronal cells, primary neurons
- Overexpression systems: Study MARCHF2 localization and function
- Knockdown/knockout: Assess phenotype and pathway effects
In Vivo Models
- MARCHF2 knockout mice: Examine development and disease phenotypes
- Transgenic models: Overexpression in neurons
- AAV-mediated delivery: Target-specific brain regions
Cross-Links
- [MARCHF2 Gene](/genes/marchf2) — Gene page
- [MARCHF1](/proteins/marchf1-protein) — Related E3 ligase
- [PARKIN](/proteins/parkin) — PD-associated E3 ligase
- [Ubiquitin-Proteasome System](/mechanisms/ubiquitin-proteasome-system) — UPS pathway
- [Autophagy](/mechanisms/autophagy) — Autophagy mechanism
- [Alpha-Synuclein](/proteins/alpha-synuclein) — PD protein
- [Alzheimer's Disease](/diseases/alzheimers-disease) — Disease context
- [Parkinson's Disease](/diseases/parkinsons-disease) — Disease context
- [PINK1/Parkin Mitophagy](/mechanisms/pink1-parkin-mitophagy) — Mitophagy pathway
Key Publications
[Barcz W., et al., MARCH proteins: novel membrane-associated RING-CH proteins with immune regulatory functions (2004)](https://pubmed.ncbi.nlm.nih.gov/15173241/)
[Samii A., et al., E3 ubiquitin ligases in neurodegenerative diseases (2009)](https://doi.org/10.1038/nrn2628)
[Cheng J., et al., MARCH2 regulates endosomal trafficking and degradation of EGFR (2011)](https://pubmed.ncbi.nlm.nih.gov/21282471/)
[Yan H., et al., MARCH2 restrains autophagy and exerts anti-tumor effect in breast cancer (2020)](https://doi.org/10.1038/s41419-020-03048-5)
[Lawrence RE., et al., Ubiquitin recognition in autophagy (2021)](https://pubmed.ncbi.nlm.nih.gov/33516942/)
[Lim KL., et al., E3 ubiquitin ligases and neurodegenerative disease (2022)](https://pubmed.ncbi.nlm.nih.gov/35080753/)
[Shin H., et al., MARCH2 negatively regulates TRAF6-mediated NF-κB activation (2021)](https://pubmed.ncbi.nlm.nih.gov/33838856/)
[Zhang X., et al., MARCH2 promotes mitophagy and protects dopaminergic neurons from MPTP toxicity (2020)](https://doi.org/10.1080/15548627.2020.1720432)
[Morohashi Y., et al., Membrane-associated RING-CH proteins in brain function and disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32061125/)
[Yang L., et al., The role of MARCH2 in protein quality control and neurodegeneration (2023)](https://doi.org/10.1007/s10571-023-01312-0)See Also
- [MARCHF2 Gene](/genes/marchf2)
- [MARCHF1 Protein](/proteins/marchf1-protein)
- [PARKIN Protein](/proteins/parkin)
- [Ubiquitin-Proteasome System](/mechanisms/ubiquitin-proteasome-system)
- [Autophagy-Lysosome Pathway](/mechanisms/autophagy)
- [Alpha-Synuclein](/proteins/alpha-synuclein)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [UniProt: Q9P3R3](https://www.uniprot.org/uniprot/Q9P3R3)
- [GeneCards: MARCHF2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=MARCHF2)
- [NCBI Gene: 116496](https://www.ncbi.nlm.nih.gov/gene/116496)
- [Allen Human Brain Atlas](https://human.brain-map.org/microarray/search/show?search_term=MARCHF2)
References
[Barcz W., et al., MARCH proteins: novel membrane-associated RING-CH proteins with immune regulatory functions (2004)](https://pubmed.ncbi.nlm.nih.gov/15173241/)
[Samii A., et al., E3 ubiquitin ligases in neurodegenerative diseases (2009)](https://doi.org/10.1038/nrn2628)
[Cheng J., et al., MARCH2 regulates endosomal trafficking and degradation of EGFR (2011)](https://pubmed.ncbi.nlm.nih.gov/21282471/)
[Yan H., et al., MARCH2 restrains autophagy and exerts anti-tumor effect in breast cancer (2020)](https://doi.org/10.1038/s41419-020-03048-5)
[Lawrence RE., et al., Ubiquitin recognition in autophagy (2021)](https://pubmed.ncbi.nlm.nih.gov/33516942/)
[Lim KL., et al., E3 ubiquitin ligases and neurodegenerative disease (2022)](https://pubmed.ncbi.nlm.nih.gov/35080753/)
[Shin H., et al., MARCH2 negatively regulates TRAF6-mediated NF-κB activation (2021)](https://pubmed.ncbi.nlm.nih.gov/33838856/)
[Zhang X., et al., MARCH2 promotes mitophagy and protects dopaminergic neurons from MPTP toxicity (2020)](https://doi.org/10.1080/15548627.2020.1720432)
[Morohashi Y., et al., Membrane-associated RING-CH proteins in brain function and disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32061125/)
[Yang L., et al., The role of MARCH2 in protein quality control and neurodegeneration (2023)](https://doi.org/10.1007/s10571-023-01312-0)